Rifamexil
Rifamexil is an antibiotic Rifamycin (HY-B1907A) derivative that is active against Mycobacterium avium complex and other mycobacteria[1].
Product Specifications
CAS Number
[113102-19-5]
UNSPSC
12352005
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rifamexil.html
Smiles
O=C1C2=C(OC1(O/C=C\C(C(C(C(C(C(C(O)C(C)/C=C/C=C(C)/C3=O)C)O)C)OC(C)=O)C)OC)C)C(C)=C(O)C4=C(O)C(N3)=C(SC(N(CC)CC)=N5)C5=C24
Molecular Formula
C42H55N3O11S
Molecular Weight
809.96
References & Citations
[1]Bacchi A, et al. Polymorphism-structure relationships of rifamexil, an antibiotic rifamycin derivative. Mol Pharmacol. 1995 Mar;47 (3) :611-23.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-135285/Rifamexil-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135285/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Anti-Peroxiredoxin 5/PRDX5 Antibody Picoband®, Carrier-free
Myeloid Leukemia Factor 1, NT (MLF1, Hls7, Myelodysplasia Myeloid Leukemia Factor 1) (APC)
Myeloid Leukemia Factor 1, NT (MLF1, Hls7, Myelodysplasia Myeloid Leukemia Factor 1) (APC)